-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Revance Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2012 to 2023.
- Revance Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $5.26M, a 16.9% increase year-over-year.
- Revance Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $20.1M, a 5.65% increase year-over-year.
- Revance Therapeutics, Inc. annual Interest Expense for 2023 was $19.4M, a 17.5% increase from 2022.
- Revance Therapeutics, Inc. annual Interest Expense for 2022 was $16.5M, a 163% increase from 2021.
- Revance Therapeutics, Inc. annual Interest Expense for 2021 was $6.27M, a 58.6% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)